EDT

Western Forest Products Inc. Announces Release Date of First Quarter 2024 Results and Conference Call Details

Retrieved on: 
Thursday, March 28, 2024
PDT, Senior, Marketing, TSX, Corporate development, EDT

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) first quarter 2024 financial and operating results will be released on Tuesday, May 7, 2024.

Key Points: 
  • VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) first quarter 2024 financial and operating results will be released on Tuesday, May 7, 2024.
  • Western will host its first quarter 2024 analyst conference call on Wednesday, May 8, 2024 at 12:00 p.m. PDT (3:00 p.m. EDT).
  • Steven Hofer, President and Chief Executive Officer, Stephen Williams, Executive Vice President and Chief Financial Officer, Bruce Alexander, Senior Vice President, Sales, Marketing and Manufacturing and Glen Nontell, Vice President, Corporate Development, will discuss the Company’s first quarter 2024 results followed by a question and answer session with the analyst community.
  • To join the conference call, dial:
    Toll-free from Canada and the US: 1-800-952-5114
    To access the instant replay of the call, dial:
    Toll-free from Canada and the US: 1-800-408-3053
    The instant replay will be available until June 8, 2024 at 8:59 p.m. PDT (11:59 p.m. EDT).

Draganfly Reports its 2023 Results

Retrieved on: 
Wednesday, March 27, 2024
PDT, International Telecommunication Union, War, Disaster, Unmanned aerial vehicle, Gross income, Internet of things, Risk, Education, EDGAR, Research, United Nations, EDT, Transport Canada, Bank statement, USASOC, Combat, Heavy lift, Army, Special forces, WMO, ITU, Marketing, Government, Artificial intelligence, UNCCD, United Nations Convention, Commander, Self storage

Saskatoon, SK., March 27, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its fourth quarter and fiscal 2023 financial results.

Key Points: 
  • Saskatoon, SK., March 27, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its fourth quarter and fiscal 2023 financial results.
  • The financial year 2023 was a transition year for Draganfly as 2023 marked new production capacity coming online along with the commercialization of its flagship Commander 3XL and Heavy Lift Drone platforms.
  • As a percentage of sales, gross margin increased from 10.4% in 2022 to 31.5% in 2023.
  • Draganfly announced record third-quarter results for 2023, recording revenue of $2,138,017, which marked a 14.0% increase from the same period the previous year.

Stryve Foods, Inc. Announces Timing of Fiscal Year 2023 Results

Retrieved on: 
Wednesday, March 27, 2024
CPG, Webcast, PIN, EDT, Software

In conjunction with the release, the Company has scheduled a conference call that will be hosted at 4:30 pm EDT Monday, April 1, 2024.

Key Points: 
  • In conjunction with the release, the Company has scheduled a conference call that will be hosted at 4:30 pm EDT Monday, April 1, 2024.
  • Dial 1-888-886-7786 or 1-416-764-8658 at least 10 minutes before the call and ask to be joined into the Stryve call.
  • A replay will be available through November 28, 2023, by dialing 1-844-512-2921 and using the replay PIN number: 96156137#.
  • An archive of the webcast will be available on the corporate website shortly after the call has concluded.

Sharecare to report fourth quarter and full year fiscal 2023 financial results on Thursday, March 28

Retrieved on: 
Wednesday, March 27, 2024
Health, EDT

ATLANTA, March 27, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR ), the digital health company that helps people manage all their health in one place, today announced that it will report fourth quarter and full year fiscal 2023 financial results on Thursday, March 28, 2024, after the market closes.

Key Points: 
  • ATLANTA, March 27, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR ), the digital health company that helps people manage all their health in one place, today announced that it will report fourth quarter and full year fiscal 2023 financial results on Thursday, March 28, 2024, after the market closes.
  • In conjunction, the company will host a conference call to review results at 4:30 p.m. EDT on the same day.
  • The conference call can be accessed by dialing (833) 636-1352 for U.S. participants, or (412) 902-4148 for international participants, and asking to be joined into the Sharecare call; or via live audio webcast, available online at https://investors.sharecare.com .
  • A webcast replay of the call will be available for on-demand listening at the same link and will remain available for approximately 90 days.

Comstock Announces 2024 Annual Meeting and Record Date

Retrieved on: 
Wednesday, March 27, 2024
PDT, Webcast, EDT, Annual general meeting

VIRGINIA CITY, Nev., March 27, 2024 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock” or the “Company”) announced today that its 2024 Annual Meeting of shareholders will be held online May 30, 2024 in a virtual-only format via webcast.

Key Points: 
  • VIRGINIA CITY, Nev., March 27, 2024 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock” or the “Company”) announced today that its 2024 Annual Meeting of shareholders will be held online May 30, 2024 in a virtual-only format via webcast.
  • Comstock shareholders as of the record date of April 2, 2024, can participate in the online annual meeting, including to vote your shares electronically and/or submit questions during the meeting.
  • The Company’s proxy statement will be sent to shareholders of record and will describe the matters to be voted upon.
  • Electronic entry to the meeting will begin at 8:30 a.m. PDT / 11:30 a.m. EDT and the meeting will begin promptly at 9:00 a.m. PDT / 12:00 p.m. EDT.

Virtu Financial to Host Conference Call Announcing First Quarter 2024 Results on Wednesday, April 24, 2024

Retrieved on: 
Wednesday, March 27, 2024
Virtu, Virtu Financial, EDT

NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the complete investment cycle to the global markets, will announce its results for the first quarter 2024 on Wednesday, April 24, 2024, before the US market open.

Key Points: 
  • NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the complete investment cycle to the global markets, will announce its results for the first quarter 2024 on Wednesday, April 24, 2024, before the US market open.
  • Virtu will host a conference call to discuss the company's financial results at 7:30 AM (EDT).
  • A live webcast of the event will be available and archived on the Investor Relations section of the company's website at https://ir.virtu.com/events-presentations .
  • The call will be open to the public.

Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023

Retrieved on: 
Wednesday, March 27, 2024
Financial statement, Growth, Infertility, International, IVF, Travel, EDT, Acquisition, Laboratory, Consumables, Adjustment, Investment, Depreciation, Analysis, Marketing, Hand, Bookkeeping

Results of Operations for the Year ended December 31, 2023

Key Points: 
  • Results of Operations for the Year ended December 31, 2023
    Hamilton Thorne sales increased 16% to $67,225,476 for the year-ended December 31, 2023, an increase of $9,047,409 from $58,178,067 during the previous year.
  • Consumable sales in 2023 outpaced the Company’s overall growth despite being affected by the recall of certain products by one of the Company’s contract manufacturers.
  • We are expecting first quarter 2024 reported revenues of between $19.0 to 19.4M, with organic growth for the quarter of approximately 8%.
  • Financial Statements and accompanying Management Discussion and Analysis for the periods are available on www.sedar.com and the Hamilton Thorne website.

LogicMark, Inc. Reschedules Release of Fourth Quarter and Full Year 2023 Financial Results to April 1, 2024

Retrieved on: 
Wednesday, March 27, 2024
PDT, Growth, CFO, EDT, LGMK, Patent, Marketing, PERS

LogicMark now expects to release results before the market opens on Monday, April 1, 2024.

Key Points: 
  • LogicMark now expects to release results before the market opens on Monday, April 1, 2024.
  • Investors and analysts wishing to participate in the conference call must register to obtain their dial-in and pin number here: https://register.vevent.com/register/BI3e8bde93af4144ae98420eb4f2c24f1c .
  • To listen to the live webcast, please visit the LogicMark Investor Relations website here , or use the following link: https://edge.media-server.com/mmc/p/z449z9mq .
  • Forward-looking statements reflect management’s current expectations, as of the date of this press release, and involve certain risks and uncertainties.

iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases

Retrieved on: 
Wednesday, March 27, 2024
Transforming growth factor beta, Eli Lilly, Atrophy, DVM, Obesity, Drug discovery, Exercise, Partnership, Patient, SAN, EDT, Learning, Entrepreneurship, IND, Antibody, Drug development, PIPE, Pharmaceutical industry

BRYAN, Texas and SAN DIEGO, March 27, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”) announces today that it has entered into a collaboration agreement with AstralBio, Inc. (“AstralBio”) to discover, engineer and develop novel antibodies to treat obesity and other cardiometabolic conditions.

Key Points: 
  • Yesterday, iBio announced the closing of a $15 million private placement financing with ADAR1 Capital Management, Lynx1 Capital Management, Ikarian Capital and other institutional investors.
  • The company will use a portion of the net proceeds to support new partnerships, such as this collaboration with AstralBio.
  • The goal of this transformative collaboration is to rapidly build a novel, best-in-class cardiometabolic disease portfolio by combining iBio’s ability to create antibodies against hard-to-drug targets with AstralBio’s significant biologics experience and drug development expertise.
  • iBio has the exclusive option to license three (3) cardiometabolic targets from AstralBio and will receive the rights to develop, manufacture and commercialize those targets upon exercise.

Getty Realty Corp. To Report First Quarter 2024 Financial Results

Retrieved on: 
Wednesday, March 27, 2024
Webcast, GTY, EDT

NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Getty Realty Corp. (NYSE: GTY) will release its financial results for the first quarter ended March 31, 2024, after the market closes on Thursday, April 25, 2024.

Key Points: 
  • NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Getty Realty Corp. (NYSE: GTY) will release its financial results for the first quarter ended March 31, 2024, after the market closes on Thursday, April 25, 2024.
  • Getty Realty Corp. will host a conference call and webcast on Friday, April 26, 2024, at 8:30 a.m. EDT.
  • To participate in the call, please dial 1-877-423-9813, or 1-201-689-8573 for international participants, ten minutes before the scheduled start.
  • If you cannot participate in the live event, a replay will be available on Friday, April 26, 2024, beginning at 11:30 a.m. EDT through 11:59 p.m. EDT, Friday, May 3, 2024.